Angiotensin 1-7

Angiotensin 1-7 has been studied in 2 papers since 2018: none in people yet, 2 in animals. The research so far is in animals. The newest paper, May 14, 2024: “Combining experiments and bioinformatics to identify transforming growth factor-β1 as a key regulator in angiotensin II-induced trophoblast senescence”.

Intervention

2 papers study it29 more mention it2 findingsUpdated

PubChemChEBI

None of its findings points the other way.

  • 1 lab in 1 country
  • Funders: Japan Society for the Promotion of Science and 2 more
  • Animals2

What did studies of Angiotensin 1-7 find?

2

Studies of Angiotensin 1-7 measured 2 outcomes; the most studied are p16INK4a expression (1 study) and grip strength (1).

p16INK4a expression

no changein mice1

1 study
  1. Angiotensin 1-7 has no effect on p16INK4a expression in mice.

    “Angiotensin 1-7 did not alter the expression of p16INK4a or central nuclei in TA muscles of both types of mice.”

    AnimalsWild-type and ACE2KO micetibialis anterior muscle4 weeksmales

    Angiotensin-converting enzyme 2 deficiency accelerates and angiotensin 1-7 restores age-related muscle weakness in mice

    Journal of cachexia, sarcopenia and muscle

More on p16INK4a expression

Grip strength

upin mice1

1 study
  1. Angiotensin 1-7 improves grip strength in mice (+3.8 ± 1.5% in wild-type and +13.3 ± 3.1% in ACE2KO mice).

    “Angiotensin 1-7 improved grip strength in both types of older mice, with larger effects observed in ACE2KO mice”

    AnimalsWild-type and ACE2KO mice4 weeksmales

    Angiotensin-converting enzyme 2 deficiency accelerates and angiotensin 1-7 restores age-related muscle weakness in mice

    Journal of cachexia, sarcopenia and muscle

Funding

2 grants since 2019

National Heart, Lung, and Blood InstituteUS$106kNational Institute on AgingUS$50k

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 02 papers in 12 months